Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet GODT SMIL HORSENS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   1.6% 1.6% 1.3% 1.9% 1.0% 1.0% 10.1% 9.9%   Credit score (0-100)   76 77 79 69 86 84 24 25   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   6.7 16.6 71.1 2.1 325.5 310.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   12,551 13,882 14,493 16,683 13,777 13,206 0.0 0.0   EBITDA   1,170 2,778 2,770 3,543 1,517 1,408 0.0 0.0   EBIT   596 2,352 2,360 3,149 1,155 1,050 0.0 0.0   Pre-tax profit (PTP)   595.0 2,365.0 2,349.8 3,140.9 1,101.8 1,021.1 0.0 0.0   Net earnings   463.2 1,843.7 1,827.1 2,449.9 854.1 794.7 0.0 0.0   Pre-tax profit without non-rec. items   595 2,365 2,350 3,141 1,102 1,021 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,832 1,592 1,358 1,289 1,003 842 0.0 0.0   Shareholders equity total   1,060 1,904 1,731 1,931 1,785 2,080 1,955 1,955   Interest-bearing liabilities   142 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,110 4,529 5,091 5,788 3,701 4,303 1,955 1,955   Net Debt   131 -1,592 -2,207 -3,147 -1,367 -2,250 -1,955 -1,955     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   12,551 13,882 14,493 16,683 13,777 13,206 0.0 0.0   Gross profit growth   -11.1% 10.6% 4.4% 15.1% -17.4% -4.1% -100.0% 0.0%   Employees   17 16 17 20 19 19 0 0   Employee growth %   -5.6% -5.9% 6.3% 17.6% -5.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,110 4,529 5,091 5,788 3,701 4,303 1,955 1,955   Balance sheet change%   -37.0% 45.6% 12.4% 13.7% -36.1% 16.3% -54.6% 0.0%   Added value   1,169.8 2,778.1 2,769.9 3,542.8 1,548.8 1,407.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,020 -665 -644 -463 -648 -518 -842 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   4.7% 16.9% 16.3% 18.9% 8.4% 8.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   15.1% 62.1% 49.4% 58.2% 24.6% 26.5% 0.0% 0.0%   ROI %   29.4% 133.8% 105.5% 131.1% 52.9% 52.1% 0.0% 0.0%   ROE %   25.3% 124.4% 100.5% 133.8% 46.0% 41.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   36.5% 44.6% 36.2% 34.5% 51.0% 50.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   11.2% -57.3% -79.7% -88.8% -90.1% -159.8% 0.0% 0.0%   Gearing %   13.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   15.1% 12.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 1.1 1.3 1.3 1.8 1.9 0.0 0.0   Current Ratio   0.7 1.3 1.3 1.4 2.0 2.1 0.0 0.0   Cash and cash equivalent   11.0 1,591.8 2,206.6 3,146.6 1,366.6 2,249.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -617.3 599.6 958.2 1,219.7 1,348.5 1,794.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   69 174 163 177 82 74 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   69 174 163 177 80 74 0 0   EBIT / employee   35 147 139 157 61 55 0 0   Net earnings / employee   27 115 107 122 45 42 0 0